243 related articles for article (PubMed ID: 10606163)
1. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
3. DNA-protective activity of new ribonucleotide reductase inhibitors.
Rauko P; Romanova D; Miadokova E; Macakova K; Novotny L; Elford HL; Szekeres T
Anticancer Res; 1997; 17(5A):3437-40. PubMed ID: 9413183
[TBL] [Abstract][Full Text] [Related]
4. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
[TBL] [Abstract][Full Text] [Related]
5. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
Gallicchio VS; Hughes NK; Tse KF; Gaines H
Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
[TBL] [Abstract][Full Text] [Related]
6. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
7. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
8. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
9. The effects of benzene inhalation on murine hematopoietic precursor cells (CFU-e, BFU-e and CFU-gm).
Hilderbrand RL; Murphy MJ
Int J Cell Cloning; 1983 Sep; 1(4):240-53. PubMed ID: 6668429
[TBL] [Abstract][Full Text] [Related]
10. The influence of choline chloride on murine hematopoiesis in vivo and in vitro.
Gallicchio VS; Chen MG; Gamba-Vitalo C; Watts TD
Int J Cell Cloning; 1983 Dec; 1(6):451-63. PubMed ID: 6672108
[TBL] [Abstract][Full Text] [Related]
11. Altered colony-forming activities of bone marrow hematopoietic stem cells in mice following short-term in vivo exposure to parathion.
Gallicchio VS; Casale GP; Bartholomew PM; Watts TD
Int J Cell Cloning; 1987 May; 5(3):231-41. PubMed ID: 3598245
[TBL] [Abstract][Full Text] [Related]
12. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
13. Genotoxic properties of the newly synthesized antineoplastic agents amidox, didox and trimidox.
Miadoková E; Macáková K; Podstavková S; Vlcek D
Pharmazie; 1997 Jul; 52(7):540-4. PubMed ID: 9266591
[TBL] [Abstract][Full Text] [Related]
14. In vivo administration of recombinant interleukin-2 induces granulocyte-macrophage colony formation in a murine system.
Lafreniere R; Houwen B; Rankin C; Borkenhagen K; Phillips M
J Biol Response Mod; 1990 Aug; 9(4):420-5. PubMed ID: 2395005
[TBL] [Abstract][Full Text] [Related]
15. Lithium and hematopoietic toxicity. I. Recovery in vivo of murine hematopoietic stem cells (CFU-S and CFU-Mix) after single-dose administration of cyclophosphamide.
Gallicchio VS
Exp Hematol; 1986 Jun; 14(5):395-400. PubMed ID: 3709709
[TBL] [Abstract][Full Text] [Related]
16. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
[TBL] [Abstract][Full Text] [Related]
17. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
[TBL] [Abstract][Full Text] [Related]
18. Hemopoiesis during thiamphenicol treatment. I. Stimulation of stem cells during eradication of intermediate cell stages.
Goris H; Loeffler M; Bungart B; Schmitz S; Nijhof W
Exp Hematol; 1989 Oct; 17(9):957-61. PubMed ID: 2776855
[TBL] [Abstract][Full Text] [Related]
19. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
Laerum OD; Paukovits WR
Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
